Safety and Efficacy of Bleomycin Sclerotherapy for Microcystic Lymphatic Malformation

[1]  Gang Chen,et al.  Bleomycin induces endothelial mesenchymal transition through activation of mTOR pathway: a possible mechanism contributing to the sclerotherapy of venous malformations , 2013, British journal of pharmacology.

[2]  S. Fishman,et al.  Slow-Flow Vascular Malformations , 2013 .

[3]  J. Mulliken,et al.  Mulliken and Young's vascular anomalies : hemangiomas and malformations , 2013 .

[4]  M. Ebina,et al.  Altered expression of tight junction molecules in alveolar septa in lung injury and fibrosis. , 2012, American journal of physiology. Lung cellular and molecular physiology.

[5]  Toshiyuki Yamamoto,et al.  Vascular Changes in Bleomycin-Induced Scleroderma , 2011, International journal of rheumatology.

[6]  G. Chaudry,et al.  Sclerotherapy of abdominal lymphatic malformations with doxycycline. , 2011, Journal of vascular and interventional radiology : JVIR.

[7]  D. Sainsbury,et al.  Intralesional Bleomycin Injection Treatment for Vascular Birthmarks: A 5-Year Experience at a Single United Kingdom Unit , 2011, Plastic and reconstructive surgery.

[8]  T. Kawabe,et al.  Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. , 2010, American journal of respiratory cell and molecular biology.

[9]  M. Cunningham,et al.  Lymphatic malformations: Review of current treatment , 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[10]  Z. Shihab,et al.  Acute pulmonary toxicity following intralesional administration of bleomycin for a lymphovenous malformation , 2010, Pediatric pulmonology.

[11]  J. Mulliken,et al.  Percutaneous sclerotherapy of lymphatic malformations with doxycycline. , 2008, Lymphatic research and biology.

[12]  G. Shelver,et al.  Bleomycin plasma spill-over levels in paediatric patients undergoing intralesional injection for the treatment of haemangiomas. , 2008, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[13]  P. Burrows,et al.  Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. , 2006, Journal of vascular and interventional radiology : JVIR.

[14]  K. Mason,et al.  Percutaneous treatment of low flow vascular malformations. , 2004, Journal of vascular and interventional radiology : JVIR.

[15]  P. Fourie,et al.  Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations , 2004, Pediatric Surgery International.

[16]  L. Robison,et al.  Pulmonary complications in survivors of childhood and adolescent cancer , 2002, Cancer.

[17]  S. Sleijfer.  Bleomycin-induced pneumonitis. , 2001, Chest.

[18]  R. Comis,et al.  Bleomycin pulmonary toxicity: current status and future directions. , 1992, Seminars in oncology.

[19]  N. Tsuruga,et al.  Bleomycin treatment for cystic hygroma in children. , 1977, Nihon geka hokan. Archiv fur japanische Chirurgie.

[20]  S. Carter,et al.  A clinical review of bleomycin—a new antineoplastic agent , 1973, Cancer.

[21]  Lei Wang,et al.  Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations. , 2011, Journal of vascular surgery.

[22]  D. Dearnaley,et al.  Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.